Home
Strides Pharma Science Ltd PE Ratio

Strides Pharma Science Ltd
NSE: STAR
PE
Key Highlights
- The P/E Ratio of Strides Pharma Science Ltd is 23.3 as of 22 Feb 15:30 PM .
- The P/E Ratio of Strides Pharma Science Ltd changed from 79.4 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
- The Latest Trading Price of Strides Pharma Science Ltd is ₹ 653.05 as of 21 Feb 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Strides Pharma Science Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Strides Pharma Science Ltd
Company Fundamentals for Strides Pharma Science Ltd

Strides Pharma Science Ltd
NSE: STAR
Share Price
Market Price of Strides Pharma Science Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 653.05 |
20 Feb 2025 | 636.8 |
19 Feb 2025 | 624.55 |
18 Feb 2025 | 630.3 |
17 Feb 2025 | 620.2 |
14 Feb 2025 | 642.8 |
13 Feb 2025 | 679.25 |
12 Feb 2025 | 665 |
11 Feb 2025 | 691.3 |
10 Feb 2025 | 733.8 |
SWOT Analysis Of Strides Pharma Science Ltd
BlinkX Score for Strides Pharma Science Ltd
Asset Value vs Market Value of Strides Pharma Science Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Strides Pharma Science Ltd | 6018 | 23.25 |
Sun Pharmaceuticals Industries Ltd | 394223 | 33.4 |
Divis Laboratories Ltd | 152610 | 73.8 |
Cipla Ltd | 119067 | 23.9 |
Torrent Pharmaceuticals Ltd | 102739 | 55.2 |
Dr Reddys Laboratories Ltd | 96124 | 17.9 |
Company | |
---|---|
Strides Pharma Science Ltd | 6018 |
Sun Pharmaceuticals Industries Ltd | 394223 |
Divis Laboratories Ltd | 152610 |
Cipla Ltd | 119067 |
Torrent Pharmaceuticals Ltd | 102739 |
Dr Reddys Laboratories Ltd | 96124 |
PE Ratio of Strides Pharma Science Ltd Explained
₹6018
Market cap
₹248
Earnings
23.3X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Strides Pharma Science Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Strides Pharma Science Ltd
Historical Revenue, EBITDA and Net Profit of Strides Pharma Science Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Strides Pharma Science Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Strides Pharma Science Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Strides Pharma Science Ltd
About Strides Pharma Science Ltd
- Strides Pharma Science Limited is a global pharmaceutical company headquartered in Bengaluru, India.
- The Company mainly operates in the regulated markets including key markets of US, Europe, Australia, South Africa.
- It has presence in the emerging markets largely in Africa where it has a branded business and is a pre qualified supplier to donor-funded programme though their institutional business. The Company is an integrated manufacturer and exporter of Finished Pharmaceutical Dosage forms for both branded and generic.
- It manufactures a very wide spectrum of ethical pharmaceutical products, OTC products and nutraceuticals.
- Their dosage forms range includes tablets, capsules, soft gelatin capsules, parenterals and semisolids.
Strides Pharma Science Ltd News Hub
Strides Alathur successfully concludes USFDA inspection
Strides Alathur, a wholly owned subsidiary of Strides Pharma Science (Strides) has received an Estab
Read more
19 Aug 24
Strides Pharma arm gets EIR from USFDA for Chennai facility
The good manufacturing practices (GMP) inspection was conducted from 1 April to 5 April 2024. The US
Read more
19 Aug 24
Strides Pharma hits 52-week high after dissolution of US unit
Strides Pharma, as a part of Group entites optimization exercises has liquidated its US unit by the
Read more
16 Aug 24
Strides Pharma Science to hold EGM
Strides Pharma Science announced that an Extra Ordinary General Meeting (EGM) of the Company will be
Read more
09 Aug 24